Isoflurane is considered to be a less hepatotoxic volatile anesthetic than
halothane since it not only undergoes quantitatively much less metabolism t
o form toxic reactive intermediates, but also preserves better hepatic bloo
d flow. However, the biochemical basis for the reduced hepatotoxicity has n
ot been elucidated. In this study, we examined the induction of two heat sh
ock proteins, heat shock protein 70 (HSP70) and heme oxygenase-1 (HO-1), in
the livers of rats pretreated with or without phenobarbital, followed by e
xposure to isoflurane or halothane under hypoxic conditions. In the phenoba
rbital-pretreated rats, the maximal induction of HSP70 was observed by halo
thane-hypoxia treatment, followed by a half-maximal induction by isoflurane
-hypoxia treatment, and less than 30% induction by hypoxia treatment alone.
Serum alanine aminotransferase (ALT) activity, an indicator of hepatic dys
function, which correlated well with the extent of centrilobular necrosis,
showed similar changes with increases in HSP70 mRNA. In contrast, HO-1 mRNA
was induced only by treatment with halothane-hypoxia, In addition, changes
in the expression of HSP70 and HO-1 mRNAs were correlated with their prote
in expression in the liver. In non-pretreated rats, neither isoflurane-hypo
xia exposure nor halothane-hypoxia exposure caused apparent hepatic injury.
There was also no induction of HSP70 or HO-1 mRNA by these treatments in n
on-pretreated animals. These findings demonstrate that there is a significa
nt difference in hepatic injury, and in the induction of HO-1 and HSP70 bet
ween halothane-hypoxia and isoflurane-hypoxia treatments. Isoflurane is kno
wn to be safer than halothane, which may, in part, be accounted for by the
generation of less oxidative stress in the presence of isoflurane, as asses
sed by reduced induction of heat shock proteins compared with halothane tre
atment. (C) 2001 Elsevier Science Inc. All rights reserved.